Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSULET CORPPODD · Entity 3516 | Director | February 28, 2024 | February 29, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSULET CORP
Report date February 28, 2024 · Filed February 29, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,567 |
Ending reported balance
After 2024-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-02-28 · Exercise / conversion · Acquired 11,609 · Balance 14,176 Row 2 · 2024-02-28 · Sale · Disposed 11,609 · Balance 2,567 F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $162.76 to $163.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $92.11 · Expires 2029-02-26 | Direct | 0 |
Reported balance
After 2024-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-02-28 · Exercise / conversion · Disposed 11,609 · Balance 0 F2: This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy NG Trust | 30,000 |
Reported balance
Holding disclosure · report date 2024-02-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 30,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $162.76 to $163.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F2: This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EXACT SCIENCES CORP
Report date March 23, 2026 · Filed March 23, 2026
Section 16 reporting ended · disclosed 2026-03-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-03-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-23 · Disposition to issuer · Disposed 16,406 · Balance 5,398 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Row 2 · 2026-03-23 · Disposition to issuer · Disposed 5,398 · Balance 0 F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding. |
| Common StockSEC Table I · non-derivative | IndirectBy grantor retained annuity trust | 0 |
Reported balance
After 2026-03-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-03-23 · Disposition to issuer · Disposed 7,095 · Balance 0 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration").
F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2026 Filed Mar 23, 2026 09:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Disposition to issuerCommon Stock | 7,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-118748 · ownership.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By grantor retained annuity trust Disclosed balance after: 0 F1 · price: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Read SEC document |
| March 23, 2026 Filed Mar 23, 2026 09:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Disposition to issuerCommon Stock | 5,398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-118748 · ownership.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding. Read SEC document |
| March 23, 2026 Filed Mar 23, 2026 09:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Disposition to issuerCommon Stock | 16,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-118748 · ownership.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,398 F1 · price: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 17:30 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 5,398 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-086886 · ownership.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,804 F1 · shares: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 17:30 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 5,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074409 · ownership.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,911 F1 · shares: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy. Read SEC document |
| June 13, 2024 Filed Dec 20, 2024 16:30 UTC Amendment | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-139093 · ownership.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,406 F1 · shares: On June 17, 2024, the Reporting Person filed a Form 4 which, due to an administrative error, incorrectly reported that the Reporting person had been awarded 5,444 shares of restricted stock pursuant to the Company's non-employee director compensation policy. This amendment to Form 4 is being filed to reflect the correct amount of shares awarded pursuant to the policy. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:37 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,609 | $0.00 Strike: $92.11 | $0.00 |
DisclosureSEC source: 0001127602-24-007635 · form4.xml · derivative · entry 4 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,609 shares Expires 2029-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:37 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 11,609 | $162.92 | $1,891,338.28 |
DisclosureSEC source: 0001127602-24-007635 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,567 F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $162.76 to $163.29. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:37 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 11,609 | $92.11 | $1,069,304.99 |
DisclosureSEC source: 0001127602-24-007635 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2023 Filed Dec 12, 2023 21:10 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 11,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029417 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By NG Trust Disclosed balance after: 30,000 Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,162 | $0.00 Strike: $92.11 | $0.00 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · derivative · entry 7 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,609 Underlying: Common Stock · 8,162 shares Expires 2029-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, which is fully vested, vested over a four-year period with 25% of the total award vesting on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,838 | $0.00 Strike: $74.50 | $0.00 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · derivative · entry 6 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,838 shares Expires 2028-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, which is fully vested, vested over a four-year period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 20,000 | $164.33 | $3,286,600.00 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · nonDerivative · entry 5 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,567 F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $164.02 to $164.85. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 12,925 | $165.02 | $2,132,883.50 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · nonDerivative · entry 4 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SP Trust Disclosed balance after: 0 Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 2,075 | $165.02 | $342,416.50 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By NG Trust Disclosed balance after: 41,130 Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 8,162 | $92.11 | $751,801.82 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 11,838 | $74.50 | $881,931.00 |
DisclosureSEC source: 0001127602-23-027356 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 16:21 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 3,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-036294 · doc4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,562 F1 · shares: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 20:05 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $271.56 | $4,073,400.00 |
DisclosureSEC source: 0001127602-23-017512 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By NG Trust Disclosed balance after: 43,205 F1 · kind: The transaction reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.10 to $274.48. Specifically: 4,943 shares were sold in the range of $270.10 to $270.99, with a weighted average share price of $270.60; 4,511 shares were sold in the range of $271 to $271.88, with a weighted average share price of $271.36; F3 · price: Footnote continued: 4,918 shares were sold in the range of $272.01 to $272.99, with a weighted average share price of $272.46; 500 shares were sold in the range of $273.16 to $273.69, with a weighted average share price of $273.36; and 128 shares were sold at a price of $274.48. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:14 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016718 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,567 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2024 and are settled in shares of common stock on a one-for-one basis. F2 · balance_after: Does not include 6,139 previously reported unvested restricted stock units ("RSUs"). These unvested RSUs were forfeited when Ms. Petrovic ceased to be an employee of the Registrant. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:26 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 12,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010446 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Indirect · By SP Trust Disclosed balance after: 12,925 F1 · shares: On March 15, 2023, the reporting person transferred 12,925 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:26 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 12,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010446 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,863 F1 · shares: On March 15, 2023, the reporting person transferred 12,925 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. Read SEC document |
| March 01, 2023 Filed Mar 1, 2023 22:36 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $276.63 | $4,149,450.00 |
DisclosureSEC source: 0001127602-23-007981 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Indirect · By NG Trust Disclosed balance after: 58,205 F2 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $273.09 to $279.59. Specifically: 2,985 shares were sold in the range of $273.09 to $274.07, with a weighted average share price of $273.63; 1,213 shares were sold in the range of $274.09 to $275.05, with a weighted average share price of $274.48; 2,243 shares were sold in the range of $275.10 to $276.05, with a weighted average share price of $275.46; 1,717 shares were sold in the range of $276.10 to $276.97, with a weighted average share price of $276.47; F4 · price: Footnote continued:1,518 shares were sold in the range of $277.09 to $277.92, with a weighted average share price of $277.58; 2,591 shares were sold in the range of $278 to $278.99, with a weighted average share price of $278.81; 2,733 shares were sold in the range of $279.07.78 to $279.59, with a weighted average share price of $279.33. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:36 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 833 | $276.36 | $230,207.88 |
DisclosureSEC source: 0001127602-23-007981 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,788 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:21 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 5,383 | $296.00 | $1,593,368.00 |
DisclosureSEC source: 0001127602-23-006187 · form4.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,621 F3 · shares: This transaction represents the withholding of shares upon the vesting of performance share units to cover the associated tax obligations. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:21 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 13,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006187 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,004 F2 · shares: Represents shares issued upon the satisfaction of performance criteria related to Performance Share Units ("PSUs"). The PSUs were settled in shares of common stock on a one-for-one basis. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:21 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 751 | $296.00 | $222,296.00 |
DisclosureSEC source: 0001127602-23-006187 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,325 F1 · shares: This transaction represents the withholding of shares upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 21:28 UTC | INSULET CORP PODD · Entity 3516 | Tax withholdingCommon Stock | 713 | $294.83 | $210,213.79 |
DisclosureSEC source: 0001127602-23-004867 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director · Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,076 F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,555 | $0.00 Strike: $74.50 | $0.00 |
DisclosureSEC source: 0001127602-23-001064 · form4.xml · derivative · entry 6 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,838 Underlying: Common Stock · 4,555 shares Expires 2028-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,445 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-23-001064 · form4.xml · derivative · entry 5 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,445 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $281.88 | $4,228,200.00 |
DisclosureSEC source: 0001127602-23-001064 · form4.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,789 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.63 to $289.70. Specifically: 3,144 shares were sold in the range of $278.63 to $279.62, with a weighted average share price of $279.20; 2,556 shares were sold in the range of $279.65 to $280.59, with a weighted average share price of $280.05; 2,337 shares were sold in the range of $280.66 to $281.39, with a weighted average share price of $281.13; 2,775 shares were sold in the range of $281.67 to $282.55, with a weighted average share price of $282.17; F3 · price: Footnote continued:898 shares were sold in the range of $282.73 to $283.68, with a weighted average share price of $283.33; 1,184 shares were sold in the range of $283.78 to $284.53, with a weighted average share price of $284.06; 700 shares were sold in the range of $284.82 to $285.18, with a weighted average share price of $284.89; 800 shares were sold in the range of $286.44 to $286.79, with a weighted average share price of $286.66; 300 shares were sold in the range of $287.68 to $288.45, with a weighted average share price of $288.10; 306 shares were sold in the range of $289.25 to $289.70, with a weighted average share price of $289.38. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 4,555 | $74.50 | $339,347.50 |
DisclosureSEC source: 0001127602-23-001064 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 21:04 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 10,445 | $46.22 | $482,767.90 |
DisclosureSEC source: 0001127602-23-001064 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:08 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,094 | $0.00 Strike: $74.50 | $0.00 |
DisclosureSEC source: 0001127602-22-027824 · form4.xml · derivative · entry 4 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,393 Underlying: Common Stock · 1,094 shares Expires 2028-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 21:08 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 1,094 | $74.50 | $81,503.00 |
DisclosureSEC source: 0001127602-22-027824 · form4.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:08 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 22,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027824 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NG Trust Disclosed balance after: 73,205 Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:08 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 22,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027824 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By SP Trust Disclosed balance after: 0 Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 21:09 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027082 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By SP Trust Disclosed balance after: 22,887 Read SEC document |
| December 07, 2022 Filed Dec 8, 2022 21:09 UTC | INSULET CORP PODD · Entity 3516 | GiftCommon Stock | 10,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-027082 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By NG Trust Disclosed balance after: 50,318 Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:28 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-22-023460 · form4.xml · derivative · entry 5 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,445 Underlying: Common Stock · 15,000 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:28 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $231.80 | $3,477,000.00 |
DisclosureSEC source: 0001127602-22-023460 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,695 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $226.49 to $234.46. Specifically: 200 shares were sold in the range of $226.49 to $226.50 per share, with a weighted average share price of $226.50; 500 shares were sold in the range of $228.39 to $229.33 per share, with a weighted average share price of $228.78; 1,954 shares were sold in the range of $229.56 to $230.54 per share, with a weighted average share price of $230.14; 4,126 shares were sold in the range of $230.59 to $231.56 per share, with a weighted average share price of $231.14. F3 · price: Footnote continued: 3,434 shares were sold in the range of $231.69 to $232.68 per share, with a weighted average share price of $232.19; 3,653 shares were sold in the range of $232.69 to $233.64 per share, with a weighted average share price of $233.08; 1,133 shares were sold in the range of $233.83 to $234.46 per share, with a weighted average share price of $234.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:28 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 15,000 | $46.22 | $693,300.00 |
DisclosureSEC source: 0001127602-22-023460 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,930 | $0.00 Strike: $46.22 | $0.00 |
DisclosureSEC source: 0001127602-22-018935 · form4.xml · derivative · entry 7 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,445 Underlying: Common Stock · 7,930 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,070 | $0.00 Strike: $29.26 | $0.00 |
DisclosureSEC source: 0001127602-22-018935 · form4.xml · derivative · entry 6 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,070 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $222.90 | $3,343,500.00 |
DisclosureSEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 3 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,695 F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $214.16 to $226.52. Specifically: 21 shares were sold in the range of $214.16 to $214.26 per share, with a weighted average share price of $214.26; 23 shares were sold at a price $215.19; 400 shares were sold in the range of $216.59 to $217.58 per share, with a weighted average share price of $217.09; 106 shares were sold in the range of $218.83 to $219.81 per share, with a weighted average share price of $218.89; 1,299 shares were sold in the range of $220.09 to $221.02 per share, with a weighted average share price of $220.47; 2,988 shares were sold in the range of $221.21 to $222.18 per share, with a weighted average share price of $221.68; 3,930 shares were sold in the range of $222.27 to $223.27 per share, with a weighted average share price of $222.81; 2,812 shares were sold in the range of $223.35 to $224.34 per share, with a weighted average share price of $223.75; 2,113 shares were sold in the range of $224.37 to $225.33 per share, with a weighted average share price of $224.71 and 1,308 shares were sold in the range of $225.57 to $226.52 per share, with a weighted average share price of $226.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 7,930 | $46.22 | $366,524.60 |
DisclosureSEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 2 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 7,070 | $29.26 | $206,868.20 |
DisclosureSEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F2 · balance_after: Includes 88 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:17 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 5,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036396 · doc4.xml · nonDerivative · entry 1 Petrovic Shacey · CIK 0001631895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,963 F1 · shares: These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $29.26 | $0.00 |
DisclosureSEC source: 0001127602-22-011550 · form4.xml · derivative · entry 6 Petrovic Shacey · CIK 0001631895 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,070 Underlying: Common Stock · 15,000 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:17 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 15,000 | $273.25 | $4,098,750.00 |
DisclosureSEC source: 0001127602-22-011550 · form4.xml · nonDerivative · entry 4 Petrovic Shacey · CIK 0001631895 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,607 F2 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.79 to $279.59. Specifically: 4,146 shares were sold in the range of $270.79 to $271.77 per share, with a weighted average share price of $271.35; 1,928 shares were sold in the range of $271.79 to $272.73 per share, with a weighted average share price of $272.10; 3,111 shares were sold in the range of $272.80 to $273.77 per share, with a weighted average share price of $273.30; 3,618 shares were sold in the range of $273.78 to $274.77 per share, with a weighted average share price of $274.21; 1,413 shares were sold in the range of $274.78 to $275.35 per share, with a weighted average share price of $275.08; 200 shares were sold in the range of $276.09 to $276.37 per share, with a weighted average share price of $276.23; 142 shares were sold in the range of $277.64 to $278.39 per share, with a weighted average share price of $278.20 and 442 shares were sold in the range of $278.66 to $279.59 per share, with a weighted average share price of $279.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.